Amy L. Seybert, PharmD, is Professor and Dean of the University of Pittsburgh School of Pharmacy. Additionally, she is the Dr. Gordon J. Vanscoy Endowed Chair of Pharmacy. Prior to her selection as Dean, she served as chair of the Department of Pharmacy and Therapeutics for 12 years and as the Associate Director of Pharmacy Programs at the Peter M. Winter Institute for Simulation, Education, and Research (WISER). Furthermore, she held the position of Pharmacy Residency Administrator at UPMC and the University of Pittsburgh, the largest pharmacy residency program in the country.
Dean Seybert is an accomplished faculty member who has been honored as a fellow of the American College of Clinical Pharmacy and of the American Society of Health System Pharmacists. In 2009, she received the American Society of Health System Pharmacists Research and Education Foundation Pharmacy Residency Excellence Preceptor Award. She was also named as 2021 AACP Distinguished Teaching Scholar. She has earned distinction on the University of Pittsburgh campus as well, having been recognized with the prestigious University of Pittsburgh Chancellor's Distinguished Teaching Award in 2006. Dean Seybert is the Immediate Past President of the Accreditation Council for Pharmacy Education Board of Directors (which is responsible for accrediting all PharmD programs in the United States).
Dean Seybert has developed a record of outstanding patient care and of creating programs that enhance patient-centered care in cardiovascular disease. She is recognized as an international leader in simulation education in pharmacy and, in 2013, became a certified healthcare simulation educator through the Society for Simulation in Healthcare. Additionally, she established the cardiovascular specialty residency program at the University of Pittsburgh School of Pharmacy which incorporates high-fidelity human patient simulation to advance pharmacotherapy knowledge, clinical decision making and medication safety skills in health care professionals. To date, she has trained over 100 pharmacy residents. An accomplished researcher, Dean Seybert has published over 85 manuscripts in peer-reviewed journals and has served as principal investigator on 14 grants in addition to being co-investigator on another 20 grants. Dean Seybert received her BS in pharmacy and her PharmD degree from the University of Pittsburgh. She completed her pharmacy residency in cardiovascular critical care at Tampa General Hospital before returning to Pitt Pharmacy.
Education
Cardiovascular
2019 Journal of the American College of Clinical Pharmacy Outstanding Reviewer
2020 ACC Academic Leaders Network
2018 AACP Lyman Award
Blended Simulation Progress Testing for Assessment of Practice Readiness
2018 Phi Lambda Sigma Chapter Alumni of the Year
2017 AACP Award for Excellence in Assessment
Blended Simulation Progress Testing for Assessment of Practice Readiness
2017 ASHP Residency Excellence Award: Program Nominee
2013 First Pharmacist Certified Simulation in Healthcare Educator
2012 ASHP Visiting Leaders Program, UPMC Residency Programs
2012 Finalist, The Simmy Award International Meeting for Simulation in Healthcare
2011 Society of Critical Care Medicine (SCCM), Clinical Pharmacy and Pharmacology Section Technology Patient Safety: Award for using simulation-based learning to reduce medication errors in critically ill patients
2011 Fellow, American College of Clinical Pharmacy
2011 Fellow, American Society of Health-System Pharmacists
2010 AACP, Innovations in Teaching, Honorable Mention
2010 Rho Chi Innovations in Teaching Award, University of Pittsburgh School of Pharmacy
2009 Pharmacy Residency Excellence Preceptor Award, ASHP Foundation
2008 Residency Preceptor of the Year, University of Pittsburgh School of Pharmacy
2007 AACP, Faculty Delegate
2006 Academy of Students of Pharmacy, Faculty of the Year
2006 University of Pittsburgh Chancellor's Distinguished Teaching Award
2006 Rho Chi Innovations in Teaching Award, University of Pittsburgh School of Pharmacy
2006 AACP, Innovations in Teaching, Honorable Mention
2005 Phi Lambda Sigma
2004 Heart Failure Initiative: Improving Angiotensin-Converting Enzyme Inhibitor Use for Patients with Left Ventricular Systolic Dysfunction
UPMC Performance Improvement Award, 5th Place
2002 Congestive Heart Failure Disease Management Team
UPMC Performance Improvement Award, 5th Place
2001-2002 AACP, University of Pittsburgh School of Pharmacy Faculty Delegate
2000 Academy of Students of Pharmacy, Faculty of the Year
1999-2000 AACP, University of Pittsburgh School of Pharmacy Faculty Delegate
Seybert AL, Laughlin KK, Benedict NJ, Barton CM, Rea RS. Pharmacy student response to patient-simulation mannequins to teach performance-based pharmacotherapeutics. Am J Pharm Educ 2006, 70(3): article 48. PMID: 17136169
First publication on the use of high-fidelity human patient simulation education within pharmacy. This paper established simulation as an active learning tool for clinical pharmacy education within pharmacy schools.
Seybert AL and Barton CM. Simulation-based learning to teach blood pressure assessment. Am J Pharm Educ 2007, 71(3): article 48. PMID: 17619648
First publication on the use of high-fidelity human patient simulation for physical assessment skills in a core pharmacotherapeutics course focusing on cardiovascular pharmacotherapy. Significant improvement in learner performance and confidence was demonstrated.
Seybert AL, Kobulinsky LR, McKaveney TM. Innovations in Teaching Award: Human patient simulation in a pharmacotherapy course. Am J Pharm Educ 2008, 72(2); article 37. PMID: 18483603
McIvor WR, Seybert A, Esper S. CHF from Diastolic Dysfunction in a Patient Presenting Preoperatively for an Elective Surgery. MedEdPORTAL; 2008.
Simulation case publication as a interprofessional team with the purpose of sharing our collaboration and case programming with the medical education field.
Ford DG*, Seybert AL, Smithburger PL*, Kobulinsky L, Samosky J, Kane-Gill SL. Impact of simulation-based learning on medication error rates in critically ill patients. Intens Care Med 2010;36:1526-1531. PMID: 20300731
First publication on use of simulation education impacting medication safety with a 25% reduction in medication errors in the ICU. This publication established international leadership in education as well as in use of simulation education for direct patient care impact. This pivotal work has differentiated my work in scholarship of education as it broadens the impact of my research to direct patient care and interprofessional education.
Seybert AL, Kane-Gill SL. Elective course in acute care using online learning and patient simulation. Am J Pharm Educ 2011;75: article 54. (Innovations in Teaching Invitation) PMID: 21655408
Established our innovation in education to multimodal approaches to learning.
Seybert AL. Patient Simulation in Pharmacy Education. Am J Pharm Educ 2011;75(9): article 187. (Simulation Supplement) PMID: 22171115
Bray BS, Schwartz CR, Odegard PS, Hammer DP, Seybert AL. Assessment in Simulation-based Learning. Am J Pharm Educ 2011; 75 (10) Article 208. (Simulation Supplement) PMID: 22345727
Gokhman R*, Seybert AL, Phrampus P, Darby J, Kane-Gill SL. Medication errors during medical emergencies in a large, tertiary care, academic medical center. Resuscitation 2012; 83:482-487. PMID: 22001000
Smithburger PL, Kane-Gill SL, Ruby C, Seybert AL. Comparing effectiveness of 3 learning strategies: Simulation-Based Learning, Problem-Based Learning, and Standardized Patients. Sim Healthcare 2012; 7(3):141-146. PMID: 22293664
Seybert AL, Smithburger PL, Kobulinsky LR, Kane-Gill SL. Simulation Based Learning versus Problem Based Learning in an Acute Care Pharmacotherapy Course. Sim Healthcare 2012, Jun;7(3):162-5. PMID: 22653560
Kane-Gill SL, Post JP*, Smithburger PL, Seybert AL. “Bumpâ€: Using a mobile app to enhance learning in simulation scenarios. Sim Healthcare 2012 Oct;7(5):326-7. PMID: 23032752
Smithburger PL, Kane-Gill SL, Kloet MA*, Lohr B, Seybert AL. Advancing interprofessional education through the use of high fidelity human patient simulators. Pharm Pract 2013; 11(2):61-5. PMID: 24155851
Kane-Gill SL, Williams EA*, Smithburger PL, Seybert AL. Tips for developing an integrated online and simulation course based on 6-years of experience. Pharmacy. 2013 Aug;1(1):34-42.
Wang T, Seybert AL, Hu C, Wu X, Chen Y, Guan X, Shi L. Development and Evaluation of the Application-based Case Study Program. J Pharma Care Health Sys 2015, May 22 (2:3): 138-143.
Benedict NJ, Smithburger PL, Donihi AC, Empey PE, Kobulinsky LR, Seybert AL, Waters T, Drab SR, Lutz J, Farkas D, and Meyer SM. Blended Simulation Progress Testing for Assessment of Practice Readiness. Am J Pharm Educ 2017 Feb 25: Volume 81, Issue 1, Article 14.
Ong CL*, Kane-Gill SL, Kobulinsky LR, Seybert AL. Evaluation of the impact of introducing simulation-based learning in pharmacy in Singapore. Curr Pharm Teach Learn 2018 Oct;10(10):1414-1418. doi: 10.1016/j.cptl.2018.07.004. Epub 2018 Aug 8. PMID: 30527371
Seybert AL. History of Simulation Based Learning and Vision of Future. (Pharmacy 2018, August; 6(2), Pharmacy Simulation Themed Issue, Seybert Editor)
Seybert AL, Kobulinsky LR. Simulation Based Learning: Development, Preparation, and Implementation. (November 2018, Pharmacy Special Issue "Simulation in Pharmacy Education and Beyond,†Seybert Editor)
Coons JC, Kobulinsky LR, Lutz J, Farkus D, Seybert AL. Integration of virtual electronic health record technology with simulation-based learning to advance PharmD education. Pharmacy 2018;6(4), 123. PMID: 30486520
Hedges A*, Johnson HJ, Kobulinsky LR, Estock JL, Eibling D, Seybert AL. Effects of Implementing Cross-training into Simulation-Based Team Training on Detection of Medication Errors. Pharmacy (Basel). 2019 Jan 19;7(1). pii: E13. doi: 10.3390/pharmacy7010013. PMID: 30669460
Coons JC, Benedict NJ, Seybert AL, Iasella CJ, Skledar SJ, Smith RB, Saul MS, Ensor CR. Pharmacotherapy Scholars Program-Intensive Longitudinal Training to Enhance Post-Graduate Readiness. Am J Pharm Educ. 2019 Nov;83(9):7327. doi: 10.5688/ajpe7327. PMID: 31871354
Seybert AL, Smithburger PL, Benedict NJ, Kobulinsky LR, Kane-Gill SL, Coons JC. Evidence for Simulation in Pharmacy Education. (Invited paper to JACCP 2019 Jul:2(6). https://doi.org/10.1002/jac5.1167
Haines ST and Seybert AL. Getting Beyond Learner Reactions: Elevating our Scholarship about Teaching and Learning. JACCP Themed Issue on Clinical Pharmacy Education and Training 2021 Feb:4(2):120-132. https://doi.org/10.1002/jac5.1379 (Served as Guest Co-Editor)
Smithburger PL, Kobulinsky LR, Kreider MS, Yourich BE, Seybert AL. Scalability of a remote advanced pharmacy practice experience with post graduate year one pharmacy resident preceptors. JACCP 2021 Feb;4(2):147-153. https://doi.org/10.1002/jac5.1340
Korenoski AJ, Ginn T*, Seybert AL. Use of an Immersive, Simulated Learning Game to Teach Pharmacy Students Clinical Concepts of Toxicology. Curr Teaching Learning 2021 May; 13(5);556-559. PMID: 33795110
Slain D, Goad J, Moser LR, Seybert AL. Characteristics and predictors of patient care performed by clinical department chairpersons at US schools of pharmacy. J Am Coll Clin Pharm 2021 July; https://doi.org/10.1002/jac5.1504
Seybert AL. Simulation Teaching in Essentials of Pharmacy Teaching and Learning: A Practical Resource for the New Pharmacy Academic. ACCP Press (In press 2023)
Johnson HJ, Xue Y, Kobulinsky LR, Benedict NJ, Pater KS, Dhingra S, Grbach W, Miller C, Seybert AL. Assessment of Learner Stress and Anxiety during Simulation Education. (Anticipated submission 2022)
McBane S, Alvandi P, Allen S, Anderson A, Dang Y, Elmes A, Fallon J, Herman A, Jenuszka J, Posey L, Richter S, Shrader S, Thomas M, Vitale K, Seybert AL. Overview of Implementation and Learning Outcomes of Simulation in Pharmacy Education. JACCP 2023
Seybert AL. National Clinical Skills Competition Case: Acute Cardiovascular Disease. American Society of Health-System Pharmacists Clinical Skills Competition 2003.
Seybert AL. Direct Thrombin Inhibitors in Percutaneous Coronary Interventions. Princeton-Media, Continuing Education PCI Supplement 2006.
Seybert AL. Chancellor’s Distinguished Teaching Award 2006. University Times, November 2006.
Smith KM, Sorensen T, Connor KA, Dobesh PP, Hoehns JD, Marcus KB, Pass S, Seybert AL, Shapiro NL. Value of Conducting Pharmacy Residency Training – The Organizational Perspective (2008 Task Force on Residencies) Pharmacotherapy 2010;30(12):490e–510e.
Seybert AL, Coons JC, Kobulinsky LR. Simulated Electronic Health Record Spotlight. Lippincott Wolters Kluwer, 2017.
Seybert AL. ASHP Pharmacy Residency Excellence Award: Use of Simulation Training: Altering the Environment. Published in: Letters from Pharmacy Preceptors: Pearls for Success. American Society of Health System Pharmacists, 2020. https://doi.org/10.37573/9781585286461
Cardiovascular/Critical Care Pharmacy Practice and Medication Safety
Seybert AL. Bivalirudin administration during percutaneous coronary intervention: Emphasis on high-risk patients. Pharmacotherapy 2002, 22(6):112S-118S. PMID: 12064568
Seybert AL and Coons JC*. Bivalirudin combined with provisional GP IIb/IIIa blockade is safer than heparin plus planned GP IIb/IIIa blockade during percutaneous coronary intervention. J Evid Card Med 2003, 7:173-175.
Rea RS*, Ansani NT, Seybert AL. Role of inhaled nitric oxide in adult heart or lung transplant recipients. Ann Pharmacother 2005, 39:913-7. PMID: 15769831
Coons JC*, Seybert AL, Saul MI, Kirisci L, Kane-Gill SL. Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary intervention. Ann Pharmacother 2005, 39(10):1621-6. PMID: 16105872
Rea RS*, Kane-Gill SL, Rudis MI, Seybert AL, Oyen LJ, Ou NN, Stauss JL, Kirisci L, Idrees U, Henderson SO. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. (AMVENT Trial). Crit Care Med 2006, 34(6):1617-1623. PMID: 16614583
Seybert AL, Coons JC, Zerumsky K*. Treatment of heparin-induced thrombocytopenia: Is there a role for bivalirudin? Pharmacotherapy 2006, 26(2): 229-41. PMID: 16466327
Zerumsky (Watson) K*, Seybert AL, Saul MI, Lee JS, Kane-Gill SL. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention. Pharmacotherapy 2007, 27(5):647-656. PMID: 17461699
Kane-Gill SL, Seybert AL, Lazar J, Shatzer M, Saul MI, Kirisci L, Murali S. Resource use in decompensated heart failure by disease progression category. Congest Heart Fail 2007;13:22-28. PMID: 17268207
Coley KC, Saul MI, Seybert AL.  Economic burden of not recognizing panic disorder in the emergency department.  J Emerg Med 2007;36(1):3-7. PMID: 17933481
Benedict NJ*, Seybert AL, Mathier MA. Evidence-based pharmacologic management of pulmonary arterial hypertension. Clin Ther 2007, 29(10):2134-2153. PMID: 18042471
Fanikos J, Seybert AL, Spinler S. Anticoagulation in non-ST-segment elevation acute coronary syndrome: Emerging therapeutic options. September, Formulary 2007.
Valko M, Cooper G, Seybert AL, Visweswaran S, Saul M, Hauskrecht M. Conditional anomaly detection methods for patient-management alert systems. Proc Int Conf Mach Learn 2008 Jul;2008.
Bellamy CJ*, Kane-Gill SL, Falcione BA, Seybert AL. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. J Trauma 2009;66:954-958. PMID: 19276778
Coley KC, Saul MI, Seybert AL. Economic burden of not recognizing panic disorder in the emergency department. J Emerg Med 2009;36(1):3-7. PMID: 17933481
Havrilla PL*, Kane-Gill SL, Seybert AL, Verrico MM, Reis SE. Coronary vasospasm and atrial fibrillation associated with ondansetron therapy. Ann Pharmacother 2009;43:532-536. PMID: 19261954
Smithburger PL*, Kane-Gill SL, Nestor BL, Seybert AL. Recent advancements and opinions in the treatment of hypertensive emergencies. Crit Care Nurse 2010;30(5):24-30. (cover article) PMID: 20889510
Devabhakthuni S* and Seybert AL. Oral Antiplatelet Therapy for the Management of Acute Coronary Syndromes: Defining the Role of Prasugrel. Crit Care Nurse June 30, 2010. PMID: 20592188
Smithburger PL*, Kane-Gill SL, Seybert AL. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US. Drug Saf 2010;33(10):879-888. PMID: 20812772
Smithburger PL, Seybert AL, Armahizer MJ*, Kane-Gill SL. QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions. Expert Opin Drug Saf 2010;9(5):699-712. PMID: 20377471
Coons JC, Plauger KM, Seybert AL, Sokos GG. Worsening heart failure in the setting of dronedarone initiation. Ann Pharmacother 2010;44(9):1496-1500. PMID: 20628043
Dasta JF, Boucher, BA, Brophy GM, Cohen H, Hassan E, MacLaren R, Martin S, Pass S, Seybert AL. Intravenous to oral conversion of antihypertensives: A toolkit for guideline development. Ann Pharmacother 2010;44(9):1430-47. PMID: 20702758
Gokhman R*, Smithburger PL*, Kane-Gill SL, Seybert AL. Pharmacokinetic rationale for combination therapy of pulmonary arterial hypertension. J Cardiovasc Pharmacol 2010;56:686-695. PMID: 20838230
Smithburger PL*, Kane-Gill SL, Benedict N, Falcione BA, Seybert AL. Grading the severity of drug-drug interactions in the intensive care unit: A comparison between clinical opinion and database severity ratings. Ann Pharmacother 2010; Nov;44(11):1718-24. PMID: 209959499 (36 citations)
Nguyen Q*, Valizadegan H, Seybert AL, Hauskrecht M. Sample-efficient learning with auxiliary class-label information. Annual American Medical Informatics Association (AMIA) Symposium Proceedings Volume 2011, 1004-1012. PMID: 22195160
Harinstein LM*, Kane-Gill SL, Smithburger PL, Culley CM, Reddy VK, Seybert AL. Use of an Abnormal Laboratory Value-Drug Combination Alert to Detect Drug-Induced Thrombocytopenia in Critically Ill Patients. J of Crit Care 2012, Jun;27(3):242-9. Epub 2012 Apr 18. PMID: 22520497
Abel EE*, Kane-Gill SL, Seybert AL, Kellum JK. A clinical outcomes comparison between direct thrombin inhibitors for the management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy. Am J Health Syst Pharm 2012 Sep 15;69(18):1559-67. PMID: 22935938
Smithburger PL, Seybert AL, Kane-Gill SL. Drug-Drug Interactions in the Medical Intensive Care Unit: An Assessment of the Frequency, Severity, and the Medications Involved. Int J Pharm Pract 2012 Dec;20(6):402-8. PMID:23134100 (30 citations)
Armahizer MJ*, Kane-Gill SL, Smithburger PL, Anthes AM, Seybert AL. Comparing DDI severity for clinician opinion to proprietary databases. ISRN Critical Care volume 2013, article ID 347346.
Armahizer MJ*, Seybert AL, Smithburger PL, Kane-Gill SL. Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. J Crit Care 2013 Jun;28(3):243-9. PMID: 2331212
Anthes AM*, Harinstein LM*, Smithburger PL, Seybert AL, Kane-Gill SL. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries. Pharmacoepidemiol Drug Saf 2013 Feb 26;22(5):510-516. PMID: 23440931
Kane-Gill SL, Wytiaz N*, Thompson L, Muzykovsky K, Buckley M, Cohen H, Seybert AL. A Real-World, Multicenter Assessment of Drugs Requiring Weight-Based Calculations in Overweight, Adult Critically Ill Patients. ScientificWorldJournal 2013 Nov 30;2013:909135. PMID: 24363625
Kloet MA*, Lohr BR*, Smithburger PL, Seybert AL, Kane-Gill SL. Progressive assessment of inpatient boxed warning prescriber adherence. J Patient Saf 2014 Mar 18. PMID: 24647270
Coons JC, Schwier N*, Harris J*, Seybert AL. Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction. Expert Opin Drug Metab Toxicol 2014 Apr; 10(4):609-20. PMID: 24555443
Kane-Gill SL, LeBlanc JM, Dasta JF, Devabhakthuni S, Critical Care Pharmacotherapy Trials Network. A multicenter study of the point prevalence of drug-induced hypotension in the ICU. Crit Care Med 2014 Oct;42(10): 2197-203. *Seybert AL listed as collaborator in Critical Care Pharmacotherapy Trials Network
Kane-Gill SL, Smithburger PL, Williams EA, Felton MA, Wang N, Seybert AL. Published Cases of Adverse Drug Reactions: Has the Quality of Reporting Improved over Time? Ther Adv Drug Saf 2015 Apr 6(2):38-44. PMID: 25922652
Liput SA*, Kane-Gill SL, Seybert AL, Smithburger PL. A Review of the Perceptions of Healthcare Providers and Family Members Toward Family Involvement in Active Adult Patient Care in the ICU. Crit Care Med 2016, Mar 8. PMID: 26958747
Cochran G, Bacci JL, Ylioja T, Hruschak V, Miller S, Seybert AL, Tarter R. Understanding Misuse Characteristics of Patients Prescribed Opioid Medications. J Am Pharm Assoc 2016 May-Jun;56(3):248-256.e6. PMID: 27053277
Kane-Gill SL, MacLasco AM, Saul MI, Smith TP, Kloet MA, Kim C, Anthes AM, Smithburger PL, Seybert AL. Use of Text Searching for Trigger Words in Medical Records to Identify Adverse Drug Reactions within an Intensive Care Unit Discharge Summary. Appl Clin Inform 2016;7:660-671. PMID: 27453336
Kloet MA, Lohr BR, Smithburger PL, Seybert AL, Kane-Gill SL. Prospective Assessment of Inpatient Boxed Warning Prescriber Adherence. J Patient Saf 2017 Mar;13(1):25-30. PMID: 24647270
Altawalbeh S*, Saul MI, Seybert AL, Thorpe J, Kane-Gill SL. Comparing the Impact of Intensive Care Unit Drug Use on Hospital Costs over 4-Years to a Decade Later. J Crit Care. 2018 Apr;44:77-81. [Epub 2017 Oct 19] doi: 10.1016/j.jcrc.2017.10.029. PMID: 29073536
Cochran G, Field C, Karp J, Seybert AL, Chen Q, Ringwald W, Hruschak V, Chickering S, Kincman J, Jaber A, Tarter R. A Community Pharmacy Intervention for Opioid Medication Misuse: A Pilot Randomized Clinical Trial. J Am Pharm Assoc 2018 Jul-Aug;58(4):395-403. PMID: 29691197
Gray MP*, Dziuba G, Quach K, Wong A, Smithburger PL, Seybert AL, Kane-Gill SL. Assessing Adverse Drug Reactions from Psychotropic Medications Reported to the FDA in Older Adults. Am J Geriatr Psychiatry. 2019 Feb;27(2):181-185. doi: 10.1016/j.jagp.2018.09.013. [Epub 2018 Sep 27.] PMID: 30503701
Cochran G, Chen Q, Field C, Seybert AL, Hruschak V, Jaber A, Gordon A, Tarter R. A Community Pharmacy-Led Intervention for Opioid Medication Misuse: A Small-Scale Randomized Clinical Trial. Drug Alcohol Depend. 2019 Dec 1;205:107570. doi: 10.1016/j.drugalcdep.2019.107570. Epub 2019 Oct 22. PMID: 31689641
Rice M*, Lear A*, Kane-Gill SL, Seybert AL, Smithburger PL. Pharmacy Personnel’s Involvement in Transitions of Care of Intensive Care Unit Patients: A Systematic Review. J Pharm Pract. 2020 Apr 1:897190020911524.
Korenoski A, Li A*, Kane-Gill SL, Seybert AL, Smithburger PL. Pharmacologic Treatment of Delirium in the ICU: A Review of the Literature. J Intensive Care Med. 2020;35(2):107-17. PMID: 30309280
Pruskowski J, Berenbrok L, Ruby-Scelsi CM, Seybert AL, Handler S. Medication Related 30-day Rehospitalizations in Palliative Care Patients. JACCP 2020 June:3(6). https://doi.org/10.1002/jac5.1289
Xue Y, Hu Z, Jing Y, Seybert A, Wang j, Xie X. Efficacy Assessment of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention by Data Mining and Machine-Learning Decision Tree Approaches. J Clin Pharm and Ther. 2020 Jul 6. Doi: 10.1111/jcpt.13172 PMID 3267223
Tarter RE, Kirisci L, Cochran G, Seybert A, Reynolds M, Vanyukov M. Forecasting Opioid Use Disorder at 25 Years of Age in 16-Year-Old Adolescents. J Pediatrics 2020 Oct;225: 207-213e1. PMID: 32652077
Rice M, Lear A, Kane-Gill S, Seybert AL, Smithburger PL. Pharmacy Personnel’s Involvement in Transitions of Care of Intensive Care Unit Patients; A Systematic Review. J Pharm Pract 2021 Feb;34(1):117-126. PMID: 32233830
Moreland-Head LN*, Coons JC, Seybert AL, Gray MP, Kane-Gill SL. Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. J Cardiovasc Pharmacol Ther 2021 Jul;26(4):341-348. PMID: 33403858
Peasah SK, Swart EC, Huang Y, Kane-Gill SK, Seybert AL, Patel U, Manolis C, Good CB. Disease-Modifying Medications in Patient with Rheumatoid Arthritis: Trends from 2016-2021. Arthritis Care and Research (Submitted March 2023)
ShapeSelect International/National/Local Presentations
Scholarship of Teaching and Learning
"Simulation Based Learning in Pharmacy Education" - Annual Safar Symposium, University of Pittsburgh Safar Center for Resuscitation Research, Pittsburgh, PA, May 31, 2007.
"œIntegrating Human Patient Simulator Technology into the Pharmacy and Nursing Curricula"-American Association of Colleges of Pharmacy Annual Meeting and Seminars, Orlando, FL, July 16, 2007.
"Introducing Human Patient Simulation to Pharmacy" - American Society of Health System Pharmacists, Orlando, FL, December 9, 2008.
"Introduction to Simulation: Application in Community Pharmacy Practice" - Cardinal Health Retail Business Conference, Washington, DC, July 29, 2009.
"œHuman Patient Simulation in Pharmacy Education" - Cedarville University, September 18, 2009.
"Cardiovascular Pharmacotherapy Update: Ready, Set...Practice" - University of Pittsburgh School of Pharmacy Fall Continuing Education Series, Pittsburgh, PA, November 1, 2009.
"Managing Pharmacotherapeutic Challenges: Learning Through Simulation" - Society of Critical Care Medicine’s 39th Critical Care Congress, Miami, FL, January 9, 2010.
"Simulation in Pharmacy Education" - International Meeting on Simulation in Healthcare, Phoenix, AZ, January 25, 2010.
"Safar Symposium on Simulation" - Peter M. Winter Institute for Simulation Education and Research (WISER), June 2, 2010.
"Portfolios in Experiential Education" - American Association of Colleges of Pharmacy Annual Meeting 2010, Seattle, WA, July 2010.
"Workshop with the American Journal of Pharmacy Education Editorial Board" - American Association of Colleges of Pharmacy Annual Meeting 2010, Seattle, WA, July 2010.
"Nuts and Bolts of Integrating Human Patient Simulation into the PharmD Curriculum" - American Association of Colleges of Pharmacy Annual Meeting 2010, Seattle, WA, July 2010.
"Progressive Learning Strategies for Foundations in Critical Thinking" - American Association of Colleges of Pharmacy Annual Meeting 2010, Seattle, WA, July 2010.
"Simulation Based Learning to Enhance Practice Skills: Trials and Triumph" - American Association of Colleges of Pharmacy Annual Meeting 2010, Seattle, WA, July 2010.
"Barriers, Hurdles, and Lessons Learned in the Scholarship of Teaching and Learning" - American College of Clinical Pharmacy, Austin, TX, October 2010.
"Critical Care PRN Focus Session" Adverse Drug Events in the ICU: Learn Using High Fidelity"
"Patient Simulation Cases- Drug-Induced Adverse Event Case 1" - American College of Clinical Pharmacy, Pittsburgh, PA, October 2011.
"Simulation in Pharmacy Education and Pharmacy Practice" - American Association of Colleges of Pharmacy, Webinar, January 25, 2012.
"Experiential Education Section: Interprofessional High-fidelity Simulations in the Curriculum: Two Innovations for the Price of One!"- American Association of Colleges of Pharmacy Annual Meeting 2012, Kissimmee, FL, July 2012.
"University of Pittsburgh School of Pharmacy: Overview of Clinical Pharmacy" - Shanghai Pharmacy Association, Shanghai, China, May 2, 2013.
"Simulation Preceptorship" - Midwestern University College of Pharmacy, Chicago, IL, June 14, 2013.
"Clinical Pharmacy in a Large US Academic Healthcare System" - Peking University, Beijing, China, May 19, 2014.
"Clinical Pharmacy in a Large US Academic Healthcare System" - Second Military University, Shanghai, China, May 20, 2014.
"Clinical Pharmacy in a Large US Academic Healthcare System" - National Clinical Pharmacy Program, Changhai Hospital, Shanghai, China, May 21, 2014.
"Simulation in Pharmacy Education" - European Association of Hospital Pharmacists 20th Annual Congress, Hamburg, Germany, March 2015.
"Assessing Effects of Cross-Training on Teamwork and Collaboration of Medical Teams" - VA Pittsburgh Healthcare System Office of Academic Affiliations Advanced Fellowships Conference, Pittsburgh, PA, May 2015.
"Simulation in Pharmacy Education: ACCP Teaching and Learning Academy Programming" -American College of Clinical Pharmacy, Phoenix, AZ, April 10, 2016.
"Simulation in Pharmacy Education: From Theory to Impact" - University of Florida Department of Pharmacotherapy and Translational Research Seminar Series, Gainesville, FL, April 14, 2016.
"University of Pittsburgh School of Pharmacy Residency Research Day" - University of Pittsburgh School of Pharmacy, Pittsburgh, PA, June 2, 2016.
"Practical Application of Simulated Learning Environments and Virtual Worlds: Benefits of Multimodality Simulation in Pharmacy Education" - American Association of Colleges of Pharmacy Annual Meeting, Anaheim, CA, July 26, 2016.
"Integration of Virtual Electronic Health Record Technology into a Core Therapeutics Course for PharmD Students" - American Association of Colleges of Pharmacy Annual Meeting, Anaheim, CA, July 27, 2016.
"Learning is NOT a Spectator Sport: Active Learning in Pharmacy Education: Stepping Up Education through Simulation" - American Association of Colleges of Pharmacy Annual Meeting, Teacher’s Seminar, Nashville, TN, July 15, 2017.
"Technology in Pharmacy Education and Learning SIG: Case Studies and Application of Emerging Technologies" - American Association of Colleges of Pharmacy Annual Meeting, Teacher's Seminar, Nashville, TN, July 16, 2017.
"Simulation Education in Health Science Education and Practice"- Texas Tech University Health Sciences Center School of Pharmacy, August 9, 2017.
"Enhancing Residents - Training with Simulation: Knowledge, Assessment and Research" - National Pharmacy Preceptors Conference, Washington, D.C., August 19, 2017.
"Hypertension Pharmacotherapy: Educating with Simulation," Clinical Pharmacist Pharmacy Service Skills International Forum, Shanghai, China, August 27, 2020.
"2020 and Beyond: How a Nimble Approach to APPE Drives Agile Patient Centered Care Experiences" ACCP Annual Meeting, October 27, 2020.
"Academic Leadership Panel: Who Does What in Academic Leadership at Pitt?". Sponsored by the Office of the Provost, October 12, 2021.
Cardiovascular/Critical Care Pharmacy Practice and Medication Safety
"Current Strategies in Antihypertensive Therapies"- University of Pittsburgh School of Pharmacy: 39th Annual Spring Continuing Education Seminar, Pittsburgh, PA. April 19, 1998.
"American College of Sports Medicine Exercise Specialist Workshop: Pharmacology" - American College of Sports Medicine Exercise Specialist Summer Workshop, June 1998.
"A Practical Update on Managing Arrhythmias: Special Challenges: Critical Dose, Narrow Therapeutic Index and Generic Substitution" - National continuing education program, Philadelphia, PA, October 31, 1998.
"Glycoprotein IIb/IIIa Platelet Receptor Inhibitor Overview"
Rhode Island Society of Hospital Pharmacists, Providence, RI, February 23, 1999.
Jefferson County Academy of Pharmacy, 37th Annual Seminar, Steubenville, OH, March 7, 1999.
New England Council of Hospital Pharmacists, 46th Annual Spring Seminar, Boston, MA, May 11, 1999.
National Council of Perfusionists, Pittsburgh, PA, May 19, 2000.
"Saturday Morning Mini Series on "Complex Drug Therapy in Cardiac and Renal Patients" - Three Rivers Chapter of American Association of Critical Care Nurses, Pittsburgh, PA. April 10,1999.
"Clinical Cardiology Updates: Acute Coronary Syndromes: A Pharmaceutical Prospective“ West Virginia University Hospitals and Clarksburg, WV, VAMC, May 4, 1999.
Chartwell Nursing Education Series - Inotropic Agents in the Home Setting - University of Pittsburgh, Johnstown, PA, June 29, 1999.
"Heart Care Partnership: A Strategy to Improve Coronary Artery Disease Outcomes for the 21st Century" -University of Pittsburgh Medical Center Health System, Pittsburgh, PA, July 20, 1999.
"Acute Coronary Syndromes: Glycoprotein II/IIIa Platelet Receptor Inhibitors"- Regional Clinical Pharmacy Meeting, Albany, NY, September 13, 1999.
"Pharmacoeconomics of Acute Coronary Syndrome Pharmacotherapy" - Southern California Managed Care Pharmacists/Clinical Pharmacists, Los Angeles, CA. September 18, 1999
"Acute Pharmacotherapy of Dysrhythmias" - Allegheny Association of Emergency Medicine Nurses, Pittsburgh, PA. October 21, 1999.
"Update on Intravenous Amiodarone Therapy" - Western Pennsylvania Nurses Association, Pittsburgh, PA, January 26, 2000.
"Drug Protocols in Advanced Cardiac Life Support" - Pennsylvania Society of Health System Pharmacists, Pittsburgh, PA, March 23, 2000.
"Evaluating the Evidence: Low Molecular Weight Heparins in Clinical Practice" - Ohio Society of Hospital Pharmacists, Columbus, OH, September 12, 2000.
"Unstable Angina/NSTEMI Guidelines: Pharmacotherapy"- Alabama Society of Health System Pharmacists, Birmingham, AL, September 13, 2000.
"Acute Coronary Syndromes: Focus on Glycoprotein IIb/IIIa Antiplatelet Agents"- University of Alabama, AL, September 14, 2000.
"New Evidence for the Management of Acute Coronary Syndromes"- American Society of Health System Pharmacists Midyear Meeting, Las Vegas, NV, December 4, 2000.
"Update on Acute Coronary Syndromes: Overview of New ACC/AHA Guidelines for Unstable Angina" Third Annual Forum for Pharmacy Directors, Pittsburgh, PA, February 24, 2001.
"Chronic Pharmacotherapy of Cardiovascular Disease“ - Altoona Family Practice Grand Rounds, Altoona Hospital, Altoona, PA, May 15, 2001.
"Evaluating the Evidence: Low Molecular Weight Heparins in Clinical Practice" - Ohio Society of Health System Pharmacists, Columbus, OH, September 12, 2000.
"Unstable Angina/NSTEMI Guidelines: Pharmacotherapy"- Alabama Society of Health System Pharmacists, Birmingham, AL, September 13, 2000.
"Acute Coronary Syndromes: Evolving Evidence" - University of Alabama Cardiovascular Grand Rounds, Birmingham, AL, September 14, 2000.
"TACTICS: Announcement of Trial Results" - American Society of Health System Pharmacists Midyear Meeting, Las Vegas, NV, December 3, 2000.
"Bivalirudin Administration During Percutaneous Coronary Intervention: Emphasis on High-Risk Patients" - The Medicine’s Company Consultant Meeting, Boca Raton, FL, January 11, 2002.
"LMWH Horizons: New Uses, New Evidence, New Agents"
West Virginia Society of Health System Pharmacists, Charleston, WV, March 21, 2002.
South-Central Alabama Society of Health System Pharmacists, Florence, AL, April 2, 2002.
Regional Pharmacy Continuing Education Program, Birmingham, AL, April 25, 2002.
"Integrating New Fibrinolytic Findings into AMI Reperfusion and Combination Therapy“ South Central Louisiana Society of Health System Pharmacists Annual Meeting, Baton Rouge, LA, April 30, 2002.
"New Drug Update: A Focus on Cardiovascular Agents"
University of Pittsburgh School of Pharmacy Alumni Weekend, Seven Springs, PA, June 8, 2002.
University of Pittsburgh Medical Center, Cardiopulmonary Nursing Workshop, Pittsburgh, PA, April 10, 2003.
"Update on Current Issues in Cardiac Pharmacology“ UPMC Presbyterian - UPMC Shadyside Cardiothoracic Nursing, Innovations 2002: A Cardiothoracic Nursing Symposium, Pittsburgh, PA, September 9, 2002.
"Comprehensive Management of Cardiovascular Disease“ University of Pittsburgh School of Pharmacy Fall Continuing Education Seminar, Pittsburgh, PA, November 17, 2002.
"Clinical Pharmacy“ University of Pittsburgh School of Pharmacy, Rho Chi Honor Society Pharmacy Overview, Pittsburgh, PA, November 15, 2002.
"Update on Drug Therapy: Focus on Common Medical Problems in Oncology Patients-Update on the Pharmacotherapeutic Management of Hypertension“ Cooper Conference Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, March 13, 2003.
"Heart Failure: What’s new in treatment?“ University of Pittsburgh Medical Center Heart Failure Awareness Week, patients with heart failure, Pittsburgh, PA, March 15, 2003.
"Pharmacology Update for Advanced Practice Clinicians-Update on Management of Hyderlipidemias and Hypertension“ University of Pittsburgh School of Nursing, Pittsburgh, PA, April 4, 2003.
"Managing Cardiovascular Risk Factors“ University of Pittsburgh School of Pharmacy 45th Annual Paul J. Wurdack Fall Continuing Education Seminar, Pittsburgh, PA, November 16, 2003.
"Updates on New Dyslipidemia Therapies“ Regional Pharmacists Program, Pittsburgh, PA, November 18, 2003.
"The Great Debate: Management of Hyperlipidemia“ Regional Physician, Nursing, and Pharmacy meeting, Pittsburgh, PA, December 10, 2003.
"Management of Heart Failure“ University of Pittsburgh Medical Center Heart Failure Awareness Week, Pittsburgh, PA, February 10, 2004.
"Heart Failure Medications" - Community Awareness Program, University of Pittsburgh Medical Center, Saturday program for patients, Pittsburgh, PA, February 21, 2004.
"Management of Heart Failure“ University of Pittsburgh Medical Center, Cardiovascular Nursing Certification Program, Pittsburgh, PA, March 3, 2004.
"Cardiac Pharmacology“ University of Pittsburgh Medical Center Health System, Shadyside and Presbyterian University Hospital Nursing Program, Pittsburgh, PA, March 25, 2004.
"The Great Debate: Phosphodiesterase 5 Inhibitors“ Regional Physician meeting, Pittsburgh, PA, May 20, 2004.
"Cardiac/Vascular Nursing Certification Review Course" - University of Pittsburgh Medical Center Health System, Shadyside and Presbyterian University Hospital Nursing Program, Pittsburgh, PA, May 19, 2005.
"High Risk Cardiovascular Patients“ Women’s Physician Health Promotion Grand Rounds, Dallas, TX, August 5, 2005.
"Optimizing Therapy in Cardiovascular Patients“ Taiwanese Asian Physician Association, Cleveland, OH, August 13, 2005.
"Angiotensin Converting Inhibitors in Heart Failur“ University of Cincinnati Cardiovascular/Nephrology Grand Rounds, Cincinnati, OH, September 14, 2005.
"Patient Safety Symposium-Heparin-Induced Thrombocytopenia"- Pittsburgh Regional Continuing Education Program, Pittsburgh, PA, November 28, 2005.
"Update on Heart Failure Guidelines“ Butler Veteran's Administration Grand Rounds, Butler, PA, January 10, 2006.
"Heparin-Induced Thrombocytopenia and Direct Thrombin Inhibitors“ Cleveland Society of Health System Pharmacists, Cleveland, OH, January 26, 2006.
"Cardiopulmonary Lecture Series-Acute Myocardial Infarction" - University of Pittsburgh Medical Center Health System, Shadyside and Presbyterian University Hospital Nursing Program, Pittsburgh, PA, January 31, 2006.
"Cardiac/Vascular Nursing Certification Review Course"- University of Pittsburgh Medical Center Health System, Shadyside and Presbyterian University Hospital Nursing Program, Pittsburgh, PA, February 8, 2006.
"Update on Antithrombin Therapy During Percutaneous Coronary Interventions“ National Continuing Education Teleconference Series, March 2006.
"Anticoagulation Therapy 2006: New Challenges for Health Systems" - Southeastern Chapter, Pennsylvania Society of Health-System Pharmacists, York, PA, September 14, 2006.
"Bivalirudin in Comparison to Unfractionated Heparin in Percutaneous Coronary Interventions at UPMC"- Northwestern Chapter, Ohio Society of Health-System Pharmacists, Toledo, OH, November 9, 2006.
"Providing Chronic Care for Patients with Diabetes and Cardiovascular Disease" - Spring Continuing Education Seminar, University of Pittsburgh School of Pharmacy and Peter M. Winter Institute for Simulation Education and Research, April 15, 2007. (Program Coordinator and Speaker)
"Evolving Anticoagulation Concepts in Acute Coronary Syndrome" - Long Island Society of Health System Pharmacists, Woodbury, NY, May 22, 2007.
"Contemporary Antithrombin Pharmacotherapy" - Southeast Regional Cardiac Catherization Laboratory Directors Meeting, Greenville, SC, August 23, 2007.
"Bivalirudin Outcomes at the University of Pittsburgh Medical Center" - Veteran’s Administration Regional Pharmacy Directors Conference, Destin, FL, October 4, 2007.
"Heparin Induced Thrombocytopenia" - New York Society of Physician Assistants, Syracuse, NY, October 14, 2007.
"Evolving Anticoagulation Concepts in Acute Coronary Syndromes" - Cleveland Society of Health System Pharmacists, Cleveland, OH, October 23, 2007.
"Evolving Anticoagulation Concepts in Acute Coronary Syndromes"- American Society of Health System Pharmacists, Las Vegas, NV, December 3, 2007.
"Commonly Used Antihypertensive Agents in the Stroke Patient" - University of Pittsburgh Medical Center, Stroke Institute, How to Excel in Acute Stroke Management Conference, Pittsburgh, PA, April 18, 2008.
"Updates in Anticoagulation Therapy" - Bayhealth Pharmacy Continuing Education Conference, Dover, DE, October 22, 2008.
"Comparison of Outcomes for Patients Receiving Bivalirudin and Unfractionated Heparin in Percutaneous Coronary Intervention" - December 4, 2006, The Medicine's Company Advisory Board.
"the Angiomax Value Proposition: Forecasting the Future" Meeting, Anaheim, CA, May 2010.
"An Overview of Antiplatelets, Antithrombins, and Anticoagulants" - American College of Cardiology, Educational Conference West, Pittsburgh, PA, May 14, 2010.
"Pulmonary Hypertension Pharmacotherapy" - American Society of Health System Pharmacy, Anaheim, CA, December 2010.
Meeting the Challenges of Contemporary PAH Management" - Academy of Managed Care Pharmacy 24th Annual Meeting 2012, San Francisco, CA, April 2012.
